✦ LIBER ✦

P-526 Phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Leighl, N.; Laurie, S.; Knox, J.; Ellis, P.; Shepherd, F.; Burkes, R.; Pond, G.; Zwiebel, J.; Moore, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of gemcitabine plus doc

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB

Phase II study of docetaxel (DOC) and ca

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Phase II trial of weekly docetaxel (D) i

✍ Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

P-20 Docetaxel and gemcitabine as second

✍ Bernardo, Maria Manuela; Sousa, Manuel; Nunes, Orlando; Gonçalves, Antonio; Mato 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

P-230 A phase II study of weekly docetax

✍ Han, Ji-Youn; Lee, Dae Ho; Kim, Hae Young; Chun, Jong Ho; Yoon, Sung Min; Lee, H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

P-588 Biweekly docetaxel and vinorelbine

✍ Vázquez, S.; Villanueva, M.; Amenedo, M.; Firvida, J.; Lázaro, M.; Del Río, L.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB